Publications | CDI Pathogenesis and Therapy - Wang Lab at Biomedical Sciences of HCOM

2025

Wang, Shaohua. 2025. “Protection of Alzheimer’s Disease Progression by a Human-Origin Probiotic Cocktail.”

Publisher's Version

2024

“Preliminary Investigations of Microbiologically Influenced Corrosion of 304 Stainless Steel by Anaerobic Clostridioides Difficile Biofilm”. 2024. International Biodeterioration & Biodegradation.

“A New Convenient Method to Assess Antibiotic Resistance and Antimicrobial Efficacy Against Pathogenic Clostridioides Difficile Biofilms”. 2024. Antibiotics.

“Revealing Roles of S-Layer Protein (SlpA) In Clostridioides Difficile pathogenicity by Generating the First slpA gene Deletion Mutant”. 2024.

Gurung, Bijay, Maranda Stricklin, and Shaohua Wang. 2024. “Gut Microbiota–Gut Metabolites And Clostridioides Difficile Infection: Approaching Sustainable Solutions for Therapy”. Metabolites.

“Abnormalities in Microbiota/Butyrate/FFAR3 Signaling in Aging Gut Impair Brain Function”. 2024.

2023

Wang, Shaohua. 2023. “The Exploration of Low-Dimensional Nanoparticles for Disease Diagnosis and Therapy.”

Wang, Shaohua. 2023. Bacterial strain useful for treatment of age-related conditions, issued 2023.

2022

Wang, Shaohua. 2022. “Protection of Cognitive Decline and Alzheimer’s Disease Progression by a Human Origin‐probiotic Biotherapy.”

2021

Wang, Shaohua. 2021. “A Novel Probiotics Therapy for Aging-Related Leaky Gut and Inflammation.”